Overexpression of LAPTM4B-35: a novel marker of poor prognosis of prostate cancer
about
Association between NQO1 C609T polymorphism and prostate cancer riskProtein tyrosine kinase 7 (PTK7) as a predictor of lymph node metastases and a novel prognostic biomarker in patients with prostate cancer.Lysosomal-associated Transmembrane Protein 4B (LAPTM4B) Decreases Transforming Growth Factor β1 (TGF-β1) Production in Human Regulatory T Cells.miR-188-5p inhibits tumour growth and metastasis in prostate cancer by repressing LAPTM4B expressionMicroRNA-195 suppresses tumor cell proliferation and metastasis by directly targeting BCOX1 in prostate carcinoma.LAPTM4B: an oncogene in various solid tumors and its functions.Targeting a novel cancer-driving protein (LAPTM4B-35) by a small molecule (ETS) to inhibit cancer growth and metastasis.Expression of RABEX-5 and its clinical significance in prostate cancer.Lentivirus-mediated RNA Interference Targeting LAPTM4B Inhibits Human Ovarian Cancer Cell Invasion In Vitro.Lysosome-associated protein transmembrane-4β-35 is a novel independent prognostic factor in small cell lung cancer.LAPTM4B is associated with poor prognosis in NSCLC and promotes the NRF2-mediated stress response pathway in lung cancer cells.Association between LAPTM4B gene polymorphism and prostate cancer susceptibility in an Iranian population.Association between IRS-1 Gly972Arg polymorphism and colorectal cancer risk.Lysosome-associated protein transmembrane4β is involved in multidrug resistance processes of colorectal cancer.Association between LAPTM4B gene polymorphism and breast cancer susceptibility in an Iranian population.LAPTM4B-35 is a novel prognostic factor for glioblastoma.
P2860
Q28240340-B8E8F8D9-D826-4AD5-9A63-272AA21B2F8CQ34072263-10C0F5D7-85C0-457B-A373-C83ABCA79A22Q35679014-1635CA6A-8EEE-45EF-BA51-E5C664C4D5ADQ35742473-B43049E9-3ECB-4004-AFBF-533878B87B07Q36025254-57D4994C-96F2-414E-B29A-5800DD7F5C7FQ37510652-C48A55B4-1C89-480E-908C-F263C9FDF718Q37629059-083D15E0-3AFA-452B-BFC1-D06E4A26917EQ37718867-D3D1593E-BD2F-4560-A76B-B3BCD2D1773CQ38845980-20A9524A-8C3D-46D1-9DDD-CA9E296A639FQ41016802-C5DC14B4-F416-4F60-8A49-DBDCF2EE3B3BQ41401802-CE736B9E-5423-4867-9FE0-01B0FEF7D2DAQ42351255-B0754700-1E98-405A-89D2-2BB4ACB46381Q44635848-40933005-7CB6-465F-AC43-BAC3CD1C4509Q45808302-61DD989C-FA6A-451F-9032-56C1AFEA7648Q46156792-81F99613-1ADA-4A22-9630-60CBBE7E93FCQ48342411-5C112CDA-A8B9-45A2-98BF-4AE4AE7DEACA
P2860
Overexpression of LAPTM4B-35: a novel marker of poor prognosis of prostate cancer
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Overexpression of LAPTM4B-35: a novel marker of poor prognosis of prostate cancer
@ast
Overexpression of LAPTM4B-35: a novel marker of poor prognosis of prostate cancer
@en
Overexpression of LAPTM4B-35: a novel marker of poor prognosis of prostate cancer
@nl
type
label
Overexpression of LAPTM4B-35: a novel marker of poor prognosis of prostate cancer
@ast
Overexpression of LAPTM4B-35: a novel marker of poor prognosis of prostate cancer
@en
Overexpression of LAPTM4B-35: a novel marker of poor prognosis of prostate cancer
@nl
prefLabel
Overexpression of LAPTM4B-35: a novel marker of poor prognosis of prostate cancer
@ast
Overexpression of LAPTM4B-35: a novel marker of poor prognosis of prostate cancer
@en
Overexpression of LAPTM4B-35: a novel marker of poor prognosis of prostate cancer
@nl
P2093
P2860
P3181
P1433
P1476
Overexpression of LAPTM4B-35: a novel marker of poor prognosis of prostate cancer
@en
P2093
Hongtuan Zhang
Peihe Liang
Shiyong Qi
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0091069
P407
P577
2014-01-01T00:00:00Z